Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Theophylline Effect in Acute Ischemic Stroke Trial
2013-001989-42Phase 2Terminated
- Sponsor
- Boris Modrau
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke comparing rtPA + theophylline with rtPA + placebo (2 arms). Primary endpoints: Infarct growth on MRI and Early clinical outcome. Started Aug 2013; status: terminated.
02
Drugs
theophylline
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2013-001989-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001989-42.